With STAAR Surgical (NASDAQ: STAA) shares down more than 50% in the past six months, stockholders are in sore need of some good news. Despite the company's decent pace of revenue and earnings growth and minimal debt, shareholders may not have much to look forward to right now from this maker of implantable lenses for vision correction.
That's quite a change. Over the past five years, STAAR has been a great investment with its shares still up more than 700%. How could a stock that flew so high be struggling so much? And is it worth buying while its shares are down from their heights? Let's take a look at what's going right and what's going wrong to find out.
Image source: Getty Images.
For further details see:
Down Over 50% in 6 Months, Is STAAR Surgical Still a Buy?